Immunosuppressive and cytotoxic therapy for pulmonary sarcoidosis-Reference-Cited by-同舟云学术

Immunosuppressive and cytotoxic therapy for pulmonary sarcoidosis

Published:2006-07-19 Issue:4 Volume:2008 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Paramothayan N Shanthi¹,Lasserson Toby J²,Walters E. Haydn³

Affiliation:

1. St Helier Hospital ; Sutton Surrey UK

2. St George's, University of London; Community Health Sciences; Cranmer Terrace Tooting London UK SW17 ORE

3. University of Tasmania Medical School; Discipline of Medicine; 43, Collins Street PO BOX 252-34 Hobart Tasmania Australia 7001

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD003536.pub2/fullpdf

Reference49 articles.

1. Randomised trial of prolonged chloroquine therapy in advanced pulmonary sarcoidosis;Baltzan;American Journal of Respiratory and Critical Care Medicine,1999

2. Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial;Baughman;Sarcoidosis Vasculitis and Diffuse Lung Diseases,2000

3. Chloroquine in the treatment of sarcoidosis;British Tuberculosis Association;Tubercle,1967

4. Manganiello VC Park MK Stylianou M Litzenberger R Jackson K Tsygansky Y A randomized trial of pentoxifylline in pulmonary sarcoidosis American Thoracic Society 2005 International Conference; May 20-25; San Diego, California 2005 A14

5. NHLBI Treatment of pulmonary sarcoidosis with pentoxifylline [Protocol 99-H-0057] clinicaltrials.gov 2005

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Pathogenesis and Progression of Sarcoidosis from the Standpoint of Tuberculosis;Integrated Science;2023

2. Serum amyloid A/anti-CCL20 induced the rebalance of Th17/regulatory T cells in SodA-induced sarcoidosis;International Immunopharmacology;2022-08

3. Potential therapeutic targets to prevent organ damage in chronic pulmonary sarcoidosis;Expert Opinion on Therapeutic Targets;2022-01-20

4. IDENTIFYING A CORE OUTCOME SET FOR PULMONARY SARCOIDOSIS RESEARCH - THE FOUNDATION FOR SARCOIDOSIS RESEARCH - SARCOIDOSIS CLINICAL OUTCOMES TASKFORCE (SCOUT);SARCOIDOSIS VASC DIF;2022

5. Treatment of Sarcoidosis: A Multidisciplinary Approach;Frontiers in Immunology;2020-11-19